From lab to commercialization: Navigate the evolving risks of life science companies -
Life science companies face rapidly evolving risks—from navigating insurance needs during early funding stages to understanding...more
6/5/2025
/ Artificial Intelligence ,
Biotechnology ,
C-Suite Executives ,
Clinical Laboratories ,
Clinical Trials ,
Commercial Insurance Policies ,
Cyber Insurance ,
Early Stage Companies ,
Emerging Growth Companies ,
Initial Public Offering (IPO) ,
Insurance Industry ,
Life Sciences ,
Research and Development ,
Risk Management ,
Risk Mitigation ,
Webinars
In this increasingly litigious and regulatory intense environment, D&O Looking Ahead provides a bridge to help you stay on top of the evolving D&O risk landscape. – Priya Huskins The streak of good news in D&O litigation...more
Woodruff Sawyer is a market leader when it comes to placing D&O insurance for companies going public through IPOs and direct listings. Experience matters for these types of transactions, and this is especially the case when...more
My partner Jane Njavro is such an expert when it comes to international D&O issues. In this guest post she gives us a briefing on key issues when it comes to placing insurance for foreign subsidiaries of US companies. – Priya...more
Multinationals continue to find themselves subject to expanding laws and regulations across the world. Add to this the heightened frequency of cross-border cooperation between regulators and you have a recipe for increased...more
In our work with multinational corporations, we routinely place insurance programs with locally admitted policies around the world, including Russia. However, on March 15, 2022, Vladimir Putin signed a law prohibiting...more